ClinicalTrials.gov
ClinicalTrials.gov Menu

CMV Intensive Care Units

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02324244
Recruitment Status : Completed
First Posted : December 24, 2014
Last Update Posted : December 24, 2014
Sponsor:
Information provided by (Responsible Party):
Emilio Bouza, Hospital General Universitario Gregorio Marañon

November 26, 2014
December 24, 2014
December 24, 2014
October 2012
May 2013   (Final data collection date for primary outcome measure)
incidence number of participants with a positive CMV positive result [ Time Frame: month 8 ]
Same as current
No Changes Posted
  • risk factors for CMV reactivation [ Time Frame: month 8 ]
  • mortality by day 30 [ Time Frame: month 8 ]
    composite endpoint. hospitalization or death by day 30
  • prolonged hospitalization . More than 30 days [ Time Frame: month 8 ]
Same as current
Not Provided
Not Provided
 
CMV Intensive Care Units
A Prospective Monitoring Study of Cytomegalovirus Infection in Immunocompetent Critical Heart Surgery Patients
Prospectively assessment of CMV viremia by real-time polymerase chain reaction (PCR) in a broad cohort of consecutive immunocompetent adults admitted to a major heart surgery intensive care unit (MHS-ICU) with the goal of determining the epidemiology, risk factors, and clinical significance of CMV infection.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
plasma samples
Non-Probability Sample
immunocompetent adults admitted to a major heart surgery intensive care unit
CMV Infection
Not Provided
immunocompetent patients underwent heart surgery
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
150
Same as current
May 2013
May 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Agreeing to participate in the study
  • Age of at least 18 years
  • Admission to the MHS-ICU for at least 72 hours

Exclusion Criteria:

  • Inability to give informed consent
  • Age younger than 18 years
  • AIDS
  • Pregnancy
  • Organ or bone marrow transplant, receipt of immunosuppressive therapy including corticosteroids within 30 days, and cancer or hematologic malignancy treated with radiotherapy or chemotherapy
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
Spain
 
 
NCT02324244
MICRO.HGUGM.2014-006
No
Not Provided
Not Provided
Emilio Bouza, Hospital General Universitario Gregorio Marañon
Emilio Bouza
Not Provided
Principal Investigator: Patricia Muñoz, PhD Hospital General Universitario Gregorio Marañon
Hospital General Universitario Gregorio Marañon
December 2014